home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

42,567 rows where posted_year = 2024 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 5

  • Supporting & Related Material 27,445
  • Other 12,059
  • Notice 2,006
  • Rule 556
  • Proposed Rule 501

agency_id 5

  • EPA 24,837
  • FDA 16,156
  • FWS 1,071
  • APHIS 323
  • USDA 180

posted_year 1

  • 2024 · 42,567 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
APHIS-2023-0088-0001 APHIS Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 Payment of Indemnity and Compensation for Highly Pathogenic Avian Influenza Rule Interim Final Rule 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z 2025-03-04T04:59:59Z 2025-03-14T01:00:15Z 2024-31384 0 0 0900006486896c83
APHIS-2022-0061-0004 APHIS Creation of United States Swine Health Improvement Plan APHIS-2022-0061 US SHIP Program Standards Supporting & Related Material Guidance 2024-12-31T05:00:00Z 2024 12     2024-12-31T14:13:38Z   0 0 0900006486888ffb
APHIS-2022-0061-0001 APHIS Creation of United States Swine Health Improvement Plan APHIS-2022-0061 U.S. Swine Health Improvement Plan Proposed Rule Notice of Proposed Rulemaking (NPRM) 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z 2025-04-01T03:59:59Z 2025-04-02T01:00:43Z 2024-31386 0 0 0900006486896dc1
APHIS-2023-0088-0004 APHIS Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 Biosecurity Audit Tool Supporting & Related Material Supplement 2024-12-31T05:00:00Z 2024 12     2024-12-31T14:16:16Z   0 0 090000648688880f
APHIS-2022-0061-0002 APHIS Creation of United States Swine Health Improvement Plan APHIS-2022-0061 PRA Abstract Supporting & Related Material Paperwork Packages 2024-12-31T05:00:00Z 2024 12     2024-12-31T14:13:21Z   0 0 0900006486888ffd
APHIS-2023-0088-0003 APHIS Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 Information Collection Abstract Supporting & Related Material Paperwork Packages 2024-12-31T05:00:00Z 2024 12     2024-12-31T14:16:11Z   0 0 0900006486888a96
APHIS-2023-0088-0002 APHIS Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 Initial Regulatory Flexibility Analysis (Economic Analysis) Supporting & Related Material Economic Analysis 2024-12-31T05:00:00Z 2024 12     2024-12-31T14:16:02Z   0 0 0900006486888ffa
APHIS-2022-0061-0003 APHIS Creation of United States Swine Health Improvement Plan APHIS-2022-0061 Initial Economic Analysis Supporting & Related Material Economic Analysis 2024-12-31T05:00:00Z 2024 12     2024-12-31T14:13:32Z   0 0 0900006486888ffc
EPA-HQ-OPPT-2024-0501-0001 EPA EPA-HQ-OPPT-2024-0501 Preliminary Lists Identifying Manufacturers Subject to Fee Obligations for Five Chemical Substances Undergoing EPA-Initiated Risk Evaluations Under the Toxic Substances Control Act (TSCA); Determination; Notice of Availability and Request for Comment Proposed Rule   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z 2025-03-04T04:59:59Z 2025-03-01T02:00:28Z 2024-30930 0 0 0900006486896ad6
EPA-HQ-OPPT-2024-0501-0003 EPA EPA-HQ-OPPT-2024-0501 High-Priority Substance Designations Under the Toxic Substances Control Act (TSCA) and Initiation of Risk Evaluation on High-Priority Substances; Notice of Availability, December 2024 Supporting & Related Material Publication - Previous/Related FR Notice 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:45:59Z   0 0 090000648687c2b9
EPA-HQ-OPPT-2024-0501-0007 EPA EPA-HQ-OPPT-2024-0501 Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, 4,4′-Methylene bis(2-chloroaniline) (MBOCA), CAS #: 101-14-4 Supporting & Related Material Data 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:47:04Z   0 0 090000648687c2f9
EPA-R09-OAR-2024-0633-0001 EPA EPA-R09-OAR-2024-0633 Receipt of Tribal Minor NSR Permit Application for Ratherford Unit WIP Mud Plant Notice   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-01T01:53:57Z   0 0 09000064868974b8
EPA-R09-OW-2023-0623-0104 EPA EPA-R09-OW-2023-0623 R9UIC_CA6_FY22_1.4 Final Permit 12.30.2024 Other   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-01T01:54:26Z   0 0 090000648689624e
EPA-HQ-OPPT-2024-0501-0004 EPA EPA-HQ-OPPT-2024-0501 Fees for the Administration of the Toxic Substances Control Act Final Rule, October 2018 Supporting & Related Material Publication - Previous/Related FR Notice 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:45:46Z   0 0 090000648687c2ba
EPA-HQ-OPPT-2024-0501-0005 EPA EPA-HQ-OPPT-2024-0501 Initiation of Prioritization Under the Toxic Substances Control Act (TSCA); Request for Comment, December 2023 Supporting & Related Material Publication - Previous/Related FR Notice 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:47:30Z   0 0 090000648687c2bb
EPA-R09-OAR-2023-0649-0011 EPA EPA-R09-OAR-2023-0649 Air Quality State Implementation Plans; Approvals and Promulgations: California; Feather River Air Quality Management District Rule   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-02T16:12:57Z 2024-31396 0 0 0900006486896c3c
EPA-R09-OW-2023-0623-0106 EPA EPA-R09-OW-2023-0623 R9UIC_CA6_FY22_1.2 Final Permit 12.30.2024 Other   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-01T01:55:30Z   0 0 0900006486896584
EPA-HQ-OPPT-2024-0501-0009 EPA EPA-HQ-OPPT-2024-0501 Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Benzenamine, CAS #: 62-53-3 Supporting & Related Material Data 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:46:38Z   0 0 090000648687c2fb
EPA-R09-OW-2023-0623-0108 EPA EPA-R09-OW-2023-0623 Notice of final permit decision - CTV I 26R (12.30.24) Notice   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-01T01:54:09Z   0 0 090000648689625d
EPA-R09-OAR-2024-0632-0001 EPA EPA-R09-OAR-2024-0632 Receipt of Tribal Minor NSR Permit Application for McElmo Creek Unit Area 4 Tank Battery Notice   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-01T01:53:43Z   0 0 09000064868974b6
EPA-R09-OW-2023-0623-0105 EPA EPA-R09-OW-2023-0623 R9UIC_CA6_FY22_1.3 Final Permit 12.30.2024 Other   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-01T01:55:12Z   0 0 0900006486896243
EPA-HQ-OPPT-2024-0501-0002 EPA EPA-HQ-OPPT-2024-0501 Fees for the Administration of the Toxic Substances Control Act (TSCA) Final Rule, February 2024 Supporting & Related Material Publication - Previous/Related FR Notice 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:46:12Z   0 0 090000648687c2b8
EPA-HQ-OPPT-2024-0501-0008 EPA EPA-HQ-OPPT-2024-0501 Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acrylonitrile, CAS #: 107-13-1 Supporting & Related Material Data 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:47:17Z   0 0 090000648687c2fa
EPA-R09-OW-2023-0623-0109 EPA EPA-R09-OW-2023-0623 Response to Comments CTV-I 26R (12.30.24) Supporting & Related Material   2024-12-31T05:00:00Z 2024 12     2025-01-01T01:54:39Z   0 0 090000648689625e
EPA-HQ-OPPT-2024-0501-0006 EPA EPA-HQ-OPPT-2024-0501 Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acetaldehyde, CAS #: 75-07-0 Supporting & Related Material Data 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:46:25Z   0 0 090000648687c2f8
EPA-R09-OW-2023-0623-0107 EPA EPA-R09-OW-2023-0623 R9UIC_CA6_FY22_1.1 Final Permit 12.30.2024 Other   2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2025-01-01T01:54:56Z   0 0 0900006486896564
EPA-HQ-OPPT-2024-0501-0010 EPA EPA-HQ-OPPT-2024-0501 Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Vinyl Chloride, CAS #: 75-01-4 Supporting & Related Material Data 2024-12-31T05:00:00Z 2024 12     2025-01-01T01:46:51Z   0 0 090000648687c2fc
FDA-2022-N-2390-0097 FDA FDA-2022-N-2390 Exhibit 208 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:54Z   0 0 09000064868a2ef0
FDA-2022-N-2390-0128 FDA FDA-2022-N-2390 Exhibit 239 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:26:26Z   0 0 09000064868a2f37
FDA-2022-N-2390-0123 FDA FDA-2022-N-2390 Exhibit 234 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:26:56Z   0 0 09000064868a2f32
FDA-2022-N-2390-0126 FDA FDA-2022-N-2390 Exhibit 237 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:26:37Z   0 0 09000064868a2f35
FDA-2022-N-2390-0090 FDA FDA-2022-N-2390 Exhibit 201 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:04Z   0 0 09000064868a2ee9
FDA-2022-N-2390-0096 FDA FDA-2022-N-2390 Exhibit 207 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:48Z   0 0 09000064868a2eef
FDA-2022-N-2390-0127 FDA FDA-2022-N-2390 Exhibit 238 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:26:31Z   0 0 09000064868a2f36
FDA-2022-N-2390-0088 FDA FDA-2022-N-2390 Exhibit 199 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:28:52Z   0 0 09000064868a3103
FDA-2022-N-2390-0103 FDA FDA-2022-N-2390 Exhibit 214 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:32:27Z   0 0 09000064868a2f07
FDA-2022-N-2390-0115 FDA FDA-2022-N-2390 Exhibit 226 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:14Z   0 0 09000064868a2f1d
FDA-2022-N-2390-0101 FDA FDA-2022-N-2390 Exhibit 212 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:32:37Z   0 0 09000064868a2f05
FDA-2022-N-2390-0107 FDA FDA-2022-N-2390 Exhibit 218 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:32:05Z   0 0 09000064868a2f0b
FDA-2022-N-2390-0120 FDA FDA-2022-N-2390 Exhibit 231 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:30:47Z   0 0 09000064868a2f2f
FDA-2024-H-5929-0001 FDA FDA-2024-H-5929 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T14:32:14Z   0 0 090000648689709d
FDA-2000-N-0011-0028 FDA Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 Uniform Compliance Date for Food Labeling Regulations Rule Final Rule 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z 2025-03-04T04:59:59Z 2025-03-05T02:00:44Z 2024-31419 0 0 0900006486896c8a
FDA-2024-N-3271-0002 FDA FDA-2024-N-3271 Flamingo Pharmaceuticals Ltd.; Withdrawal of Approval of Two Abbreviated New Drug Applications Notice Withdrawal 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T14:36:36Z 2024-31360 0 0 0900006486896c82
FDA-2024-H-5921-0001 FDA FDA-2024-H-5921 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T16:08:58Z   0 0 090000648689712d
FDA-2022-N-2390-0105 FDA FDA-2022-N-2390 Exhibit 216 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:32:18Z   0 0 09000064868a2f09
FDA-2022-N-2390-0106 FDA FDA-2022-N-2390 Exhibit 217 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:32:11Z   0 0 09000064868a2f0a
FDA-2022-N-2390-0111 FDA FDA-2022-N-2390 Exhibit 222 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:39Z   0 0 09000064868a2f19
FDA-2022-N-2390-0113 FDA FDA-2022-N-2390 Exhibit 224 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:26Z   0 0 09000064868a2f1b
FDA-2022-N-2390-0079 FDA FDA-2022-N-2390 Exhibit 190 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:27:08Z   0 0 09000064868a27cf
FDA-2022-N-2390-0084 FDA FDA-2022-N-2390 Exhibit 195 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:28:11Z   0 0 09000064868a28ff
FDA-2022-N-2390-0098 FDA FDA-2022-N-2390 Exhibit 209 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:59Z   0 0 09000064868a2ef1
FDA-2022-N-2390-0074 FDA FDA-2022-N-2390 Index to Exhibits Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:25:42Z   0 0 09000064868a4593
FDA-2022-N-2390-0080 FDA FDA-2022-N-2390 Exhibit 191 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:27:13Z   0 0 09000064868a28fb
FDA-2024-H-5925-0001 FDA FDA-2024-H-5925 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T14:58:24Z   0 0 090000648689756a
FDA-2024-H-5800-0001 FDA FDA-2024-H-5800 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T15:04:04Z   0 0 0900006486898448
FDA-2024-H-5916-0001 FDA FDA-2024-H-5916 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T15:11:03Z   0 0 0900006486898d43
FDA-2024-H-5928-0001 FDA FDA-2024-H-5928 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T14:04:26Z   0 0 0900006486897071
FDA-2024-H-5920-0001 FDA FDA-2024-H-5920 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T15:13:15Z   0 0 09000064868968ce
FDA-2024-H-5922-0001 FDA FDA-2024-H-5922 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T15:54:19Z   0 0 0900006486897104
FDA-2024-N-2980-0006 FDA FDA-2024-N-2980 Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products; Reopening of the Comment Period Notice Extension of Comment Period 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T14:48:35Z 2024-31365 0 0 0900006486896ad4
FDA-2024-H-5924-0001 FDA FDA-2024-H-5924 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T14:57:26Z   0 0 090000648689754d
FDA-2022-N-2390-0085 FDA FDA-2022-N-2390 Exhibit 196 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:28:17Z   0 0 09000064868a3100
FDA-2022-N-2390-0100 FDA FDA-2022-N-2390 Exhibit 211 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:30:11Z   0 0 09000064868a2f04
FDA-2022-N-2390-0102 FDA FDA-2022-N-2390 Exhibit 213 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:32:32Z   0 0 09000064868a2f06
FDA-2022-N-2390-0104 FDA FDA-2022-N-2390 Exhibit 215 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:32:23Z   0 0 09000064868a2f08
FDA-2022-N-2390-0112 FDA FDA-2022-N-2390 Exhibit 223 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:32Z   0 0 09000064868a2f1a
FDA-2022-N-2390-0114 FDA FDA-2022-N-2390 Exhibit 225 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:20Z   0 0 09000064868a2f1c
FDA-2022-N-2390-0117 FDA FDA-2022-N-2390 Exhibit 228 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:03Z   0 0 09000064868a2f1f
FDA-2024-H-5931-0001 FDA FDA-2024-H-5931 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T14:48:56Z   0 0 09000064868971c7
FDA-2024-H-5917-0001 FDA FDA-2024-H-5917 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T15:11:54Z   0 0 0900006486898d49
FDA-2022-N-2390-0083 FDA FDA-2022-N-2390 Exhibit 194 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:27:40Z   0 0 09000064868a28fe
FDA-2022-N-2390-0094 FDA FDA-2022-N-2390 Exhibit 205 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:37Z   0 0 09000064868a2eed
FDA-2022-N-2390-0089 FDA FDA-2022-N-2390 Exhibit 200 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:28:58Z   0 0 09000064868a3104
FDA-2022-N-2390-0075 FDA FDA-2022-N-2390 Exhibit 186 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:25:49Z   0 0 09000064868a27cb
FDA-2022-N-2390-0076 FDA FDA-2022-N-2390 Exhibit 187 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:25:55Z   0 0 09000064868a27cc
FDA-2022-N-2390-0099 FDA FDA-2022-N-2390 Exhibit 210 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:30:05Z   0 0 09000064868a2ef2
FDA-2022-N-2390-0124 FDA FDA-2022-N-2390 Exhibit 235 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:26:49Z   0 0 09000064868a2f33
FDA-2022-N-2390-0122 FDA FDA-2022-N-2390 Exhibit 233 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:30:36Z   0 0 09000064868a2f31
FDA-2022-N-2390-0109 FDA FDA-2022-N-2390 Exhibit 220 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:53Z   0 0 09000064868a2f0d
FDA-2024-H-5918-0001 FDA FDA-2024-H-5918 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T14:00:47Z   0 0 090000648689688b
FDA-2024-H-5867-0001 FDA FDA-2024-H-5867 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T14:43:58Z   0 0 09000064868968a8
FDA-2024-N-5830-0001 FDA FDA-2024-N-5830 Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal Notice Notice of Renewal 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T14:00:03Z 2024-31363 0 0 0900006486896cc5
FDA-2024-H-5926-0001 FDA FDA-2024-H-5926 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T14:59:14Z   0 0 090000648689758c
FDA-2024-H-5915-0001 FDA FDA-2024-H-5915 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T15:09:09Z   0 0 09000064868984fb
FDA-2024-H-5832-0001 FDA FDA-2024-H-5832 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T15:07:02Z   0 0 090000648689844e
FDA-2022-N-2390-0086 FDA FDA-2022-N-2390 Exhibit 197 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:28:27Z   0 0 09000064868a3101
FDA-2022-N-2390-0092 FDA FDA-2022-N-2390 Exhibit 203 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:18Z   0 0 09000064868a2eeb
FDA-2022-N-2390-0095 FDA FDA-2022-N-2390 Exhibit 206 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:43Z   0 0 09000064868a2eee
FDA-2022-N-2390-0129 FDA FDA-2022-N-2390 Exhibit 240 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:26:19Z   0 0 09000064868a2f38
FDA-2022-N-2390-0093 FDA FDA-2022-N-2390 Exhibit 204 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:32Z   0 0 09000064868a2eec
FDA-2022-N-2390-0116 FDA FDA-2022-N-2390 Exhibit 227 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:09Z   0 0 09000064868a2f1e
FDA-2022-N-2390-0118 FDA FDA-2022-N-2390 Exhibit 229 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:30:57Z   0 0 09000064868a2f20
FDA-2022-N-2390-0110 FDA FDA-2022-N-2390 Exhibit 221 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:31:47Z   0 0 09000064868a2f18
FDA-2022-N-2390-0121 FDA FDA-2022-N-2390 Exhibit 232 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:30:41Z   0 0 09000064868a2f30
FDA-2024-H-5923-0001 FDA FDA-2024-H-5923 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T16:22:10Z   0 0 0900006486897134
FDA-2024-H-5919-0001 FDA FDA-2024-H-5919 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T15:50:42Z   0 0 09000064868968fe
FDA-2024-H-5930-0001 FDA FDA-2024-H-5930 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T14:33:28Z   0 0 090000648689751e
FDA-2024-H-5914-0001 FDA FDA-2024-H-5914 Complaint Other Complaint 2024-12-31T05:00:00Z 2024 12 2025-01-02T05:00:00Z   2025-01-02T15:08:06Z   0 0 0900006486898496
FDA-2022-N-2390-0078 FDA FDA-2022-N-2390 Exhibit 189 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:26:07Z   0 0 09000064868a27ce
FDA-2022-N-2390-0091 FDA FDA-2022-N-2390 Exhibit 202 Supporting & Related Material Background Material 2024-12-31T05:00:00Z 2024 12     2025-04-04T15:29:10Z   0 0 09000064868a2eea

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 2863.628ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API